Early-stage considerations for cell and gene therapy commercialization
Sponsor
Live30 webinars are thirty-minute presentations designed to update you on the latest innovations, applications, and data in a fast yet interactive format.
The cell and gene therapy field continues to advance at an unprecedented pace. In keeping up with the complex process development landscape and changing regulatory requirements, emerging biotechs and early-stage organizations - including academia and research institutions - face unique challenges.
From process development to scale-up considerations, this webinar will provide the essential knowledge and practical insights needed to accelerate the development of safe and effective cell and gene therapies. It will also explain why you should think about commercialization now, even if you think you’re not ready for this step yet.
- Explore critical considerations in process development
- Outline strategies for scale-up and quality control
- Learn how to successfully translate to commercial-scale manufacturing
SPEAKERS
You might also like
Scalable, high titer production of AAV in the Gibco CTS AAV_Max production system
Addressing regulatory guidance for HEK293 cells and AAV-based therapeutic manufacturing
Aldevron case study: validation of mRNA concentration determination using variable pathlength spectroscopy
Enabling RNA therapeutics: innovative cationic lipids to improve LNP formulation
